rationale for genetic testing in patients with dlbcl
Published 5 years ago • 113 plays • Length 0:34Download video MP4
Download video MP3
Similar videos
-
20:48
current upfront management of dlbcl
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
22:26
key novel agents for relapsed diffuse large b-cell lymphoma
-
0:43
safety findings for axi-cel in patients with dlbcl
-
1:29
dr. weber on genetic testing for patients with melanoma
-
2:05
genetic testing could alter treatment for some lymphoma patients
-
1:56
the need for new treatment strategies for patients with dlbcl
-
20:02
what are the hurdles to using cell of origin in classification to treat dlbcl?
-
1:39
expert discusses data for flyer trial in patients with dlbcl
-
0:58
selecting and risk stratifying patients with dlbcl for asct
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
24:24
double-hit dlbcl
-
2:44
polarix study: frontline therapy in dlbcl
-
0:59
dr. nowakowski on the rationale of the engine trial in dlbcl
-
3:15
treatment limitations in dlbcl